Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,264 | 16,615 | 21,214 | 24,626 | 26,614 |
| Marketable Securities | N/A | 2,099 | 550 | N/A | 1,500 |
| Other current assets | 126 | 356 | 456 | 115 | 299 |
| TOTAL | $17,390 | $19,070 | $22,220 | $24,741 | $28,413 |
| Non-Current Assets | |||||
| PPE Net | 214 | 232 | 250 | 187 | 201 |
| Other Non-Current Assets | 0 | 0 | 12 | 12 | 12 |
| TOTAL | $214 | $232 | $262 | $199 | $213 |
| Total Assets | $17,604 | $19,302 | $22,482 | $24,940 | $28,626 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 573 | 303 | 1,083 | 378 | 1,043 |
| Accrued Expenses | 310 | 362 | 1,084 | 1,575 | 2,301 |
| TOTAL | $883 | $665 | $2,167 | $1,953 | $3,344 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $883 | $665 | $2,167 | $1,953 | $3,344 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,594 | 6,594 | 6,594 | 6,594 | 6,594 |
| Common Shares | 46 | 7 | 46 | 46 | 46 |
| Retained earnings | -148,231 | -145,488 | -142,966 | -139,448 | -136,433 |
| Other shareholders' equity | 0 | 0 | 1 | 0 | 0 |
| TOTAL | $16,721 | $18,637 | $20,315 | $22,987 | $25,282 |
| Total Liabilities And Equity | $17,604 | $19,302 | $22,482 | $24,940 | $28,626 |